Search Results - Rolf Ljung

Refine Results
  1. 1
    Intracranial haemorrhage in haemophilia A and B

    Intracranial haemorrhage in haemophilia A and B by Rolf Ljung

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The current status of prophylactic replacement therapy in children and adults with haemophilia

    The current status of prophylactic replacement therapy in children and adults with haemophilia by Rolf Ljung, Nadine G. Andersson

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Management of carriers and babies with haemophilia

    Management of carriers and babies with haemophilia by Alison Street, Rolf Ljung, Stuart Lavery

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

    Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized by Jan Astermark, Pia Petrini, Lilian Tengborn, Sam Schulman, Rolf Ljung, Erik Berntorp

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG<scp>)</scp>

    Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG<scp>)</scp> by B. M. Feldman, Sharon Funk, Björn Lundin, Andréa S. Doria, Rolf Ljung, Victor S. Blanchette

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

    Mode of delivery in hemophilia: vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds by Nadine G. Andersson, Elizabeth A. Chalmers, Gili Kenet, Rolf Ljung, Anne Mäkipernaa, Hérvè Chambost

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    The incidence and distribution of CpG←Tpg transitions in the coagulation factor IX gene. A fresh look at CPG mutitional hospots

    The incidence and distribution of CpG←Tpg transitions in the coagulation factor IX gene. A fresh look at CPG mutitional hospots by Peter M. Green, A.Jane Montandon, David Bentley, Rolf Ljung, Inga Marie Nilsson, F. Giannelli

    Published 1990
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Increased burden on caregivers of having a child with haemophilia complicated by inhibitors

    Increased burden on caregivers of having a child with haemophilia complicated by inhibitors by Karin Lindvall, Sylvia von Mackensen, Sölve Elmståhl, Kate Khair, Ann Marie Stain, Rolf Ljung, Erik Berntorp

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice

    Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice by Gary Benson, Günter Auerswald, Ivo Elezović, Thierry Lambert, Rolf Ljung, Massimo Morfini, Eduardo Remor, Silva Zupančić Šalek

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011

    Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011 by Søren Anker Uldum, Jette Bangsborg, Lars Bjerrum, Rolf Ljung, Mette Mølvadgaard, Randi Føns Petersen, Christina Wiid Svarrer

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

    Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s by Kathelijn Fischer, Katarina Steen Carlsson, Pia Petrini, Margareta Holmström, Rolf Ljung, H. Marijke van den Berg, Erik Berntorp

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors

    Secondary prophylaxis with recombinant activated factor VII improves health‐related quality of life of haemophilia patients with inhibitors by W. Keith Hoots, Liselotte S. Ebbesen, Barbara A. Konkle, G. Auerswald, Harold R. Roberts, James Weatherall, Jean-Marc Ferran, Rolf Ljung

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Pain and pain management in haemophilia

    Pain and pain management in haemophilia by Günter Auerswald, G. Dolan, Anne Duffy, Cédric Hermans, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert, Silva Zupančić Šalek

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Practical aspects of extended half-life products for the treatment of haemophilia

    Practical aspects of extended half-life products for the treatment of haemophilia by Thierry Lambert, Gary Benson, G. Dolan, Cédric Hermans, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić‐Šalek, Elena Santagostino

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Somatic Mosaicism in Hemophilia A: A Fairly Common Event

    Somatic Mosaicism in Hemophilia A: A Fairly Common Event by Marco Leuer, Johannes Oldenburg, Jean‐Maurice Lavergne, Michael Ludwig, Andreas Fregin, A. Eigel, Rolf Ljung, Anne Goodeve, I. R. Peake, Klaus Olek

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

    Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A by H. Marijke van den Berg, Kathelijn Fischer, Manuel Carção, Hérvè Chambost, Gili Kenet, Karin Kurnik, Chris Königs, Christoph Male, Elena Santagostino, Rolf Ljung

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients

    Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult‐to‐treat patients by Rolf Ljung, G. Auerswald, Gary Benson, G. Dolan, Anne Duffy, Cédric Hermans, Víctor Jiménez‐Yuste, Thierry Lambert, Massimo Morfini, Silva Zupančić‐Šalek, Elena Santagostino

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study

    Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study by Christoph Male, Nadine G. Andersson, Anne Rafowicz, Ri Liesner, Karin Kurnik, Kathelijn Fischer, Helen Platokouki, Elena Santagostino, Hérvè Chambost, Beatrice Nolan, Christoph Königs, Gili Kenet, Rolf Ljung, Marijke van den Berg, PedNet study group

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A

    Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A by Manuel Carção, H. Marijke van den Berg, Rolf Ljung, Maria Elisa Mancuso, Carmen Altisent, G. Auerswald, E Chalmers, Hérvè Chambost, Ana Rosa Cid, S. Claeyssens, Niels Clausen, Kathelijn Fischer, Van Creveld Kliniek, Ch van Geet, Kathelijne Peerlinck, Rainer Kobelt, W. Kreuz, Carmen Escuriola, Karin Kurnik, Ri Liesner, Rolf Ljung, Anne Mäkipernaa, Angelo Claudio Molinari, W. Muntean, Johannes Oldenburg, Rosario Garrido, Pia Petrini, Helen Platokouki, Anne Rafowicz, Elena Santagostino, ME Mancuso, Angela Thomas, M. Williams, SC Gouw, HM van den Berg, Gili Kenet, Manuel Carção, Georges‐Étienne Rivard

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Factor VIII Products and Inhibitor Development in Severe Hemophilia A

    Factor VIII Products and Inhibitor Development in Severe Hemophilia A by Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung, Carmen Escuriola, Ana Rosa Cid, Ségolène Claeyssens‐Donadel, Chris Van Geet, Gili Kenet, Anne Mäkipernaa, Angelo Claudio Molinari, W. Muntean, Rainer Kobelt, George E. Rivard, Elena Santagostino, Angela Thomas, H. Marijke van den Berg

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: